Flow Traders U.S.’s EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant EQHA.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-28,719
Closed -$287K 1201
2021
Q3
$287K Buy
28,719
+5,720
+25% +$56.8K 0.01% 836
2021
Q2
$229K Buy
+22,999
New +$230K 0.01% 825

Other funds holding EQHA.U

Flow Traders U.S.'s EQHA.U Position: Q4 2021 in Review

Flow Traders U.S. sold out of EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant (EQHA.U) in Q4 2021, closing a stake of 28,719 shares — an estimated $287K sold.

Flow Traders U.S. first reported a position in EQHA.U in Q2 2021 and held it in 2 quarters. The position peaked at $287K in Q3 2021. 23 funds tracked by Wall St. Rank hold EQHA.U as of Q4 2021.

  • Flow Traders U.S. reported no remaining EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position as of Q4 2021 after selling out during the quarter.
  • Flow Traders U.S. sold 28,719 EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant shares in Q4 2021, an estimated $287K.
  • Flow Traders U.S. first reported a position in EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant in Q2 2021 and held it in 2 quarters.
  • Flow Traders U.S.'s EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position peaked at $287K in Q3 2021.
  • 23 funds tracked by Wall St. Rank held EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant as of Q4 2021.

Based on Flow Traders U.S.'s 13F filing for Q4 2021, filed 14 Feb 2022.